Elliott Investment Management reckons the BP share price doesn’t reflect the true potential of the energy giant. Our writer ...

As ANZ Bank chief Shayne Elliott prepares to hand over to his successor Nuno Matos, he says banks should be ready for a more volatile world.

Shares of Charles River Laboratories gained on Wednesday after the company disclosed plans for a strategic review aimed at ...

Against this backdrop, ANZ divested about 30 businesses, including in insurance, overseas banking, and wealth management, raising billions of dollars. ANZ is now better placed to deal with uncertainty ...

Pharmaceutical company Charles River Laboratories has reached a settlement with activist investor Elliott Investment ...

Charles River CEO James Foster had previously attributed the 2024 revenue dip to decreased demand from biopharma clients. In ...

The contract research firm, which has Elliott as its largest investor, said it will initiate a comprehensive review of its business, including an examination of various other alternatives to enhance ...

Charles River Labs said first-quarter earnings rose and it's raising its full-year outlook. The company also entered into an agreement with Elliott Investment Management and said it would conduct a ...

James C. Foster, Chair, President, and CEO of Charles River Laboratories, emphasized the company’s proactive approach to navigating market conditions and its commitment to growth. Foster expressed ...

BEVERLY HILLS (Reuters) -Pharmaceutical company Charles River Laboratories has reached a settlement with activist investor Elliott Investment Management to add four new directors to its board and ...

BEVERLY HILLS (Reuters) -Pharmaceutical company Charles River Laboratories has reached a settlement with activist investor Elliott Investment Management to add four new directors to its board and ...